Knowledge and Acceptance of COVID-19 Vaccines Among Residents of Brgy.

Poblacion, Bayugan City, Agusan Del Sur

*Bascug, V. E., Famador, N. J., Jaranilla, C. M., Sayon, C. E.,

*Bayugan National Comprehensive High School

ABSTRACT

The COVID-19 outbreak wreaked havoc on healthcare systems worldwide, creating

unprecedented challenges. Several countries have used a number of strategies to limit the virus's
spread, including the creation of COVID-19 vaccinations. Despite the fact that multiple
vaccinations have been authorized and are in use, vaccine hesitancy still exists, which makes
achieving herd immunity difficult. This study aims to determine the level of knowledge and
acceptance of COVID-19 vaccines among the residents of Brgy. Poblacion, Bayugan City by
means of a web-based survey. A total of 180 respondents participated in the survey. The majority
of the respondents belong to the age group 18-29 years old (35 %), single are (49.40%), have
completed college or higher (42.20%), are within the lower middle income (36.10%), have no
chronic diseases (98.3%), are currently not infected with COVID-19 (99.4%), and were not
previously infected with COVID-19 (96.4%). The majority of the residents (86.11%) have good
knowledge, and their knowledge score is relatively high. The knowledge is significantly related
to age, civil status, monthly income, and having a family member or friend who has COVID-19.
The higher acceptance rate is significantly related to monthly income and whether the respondent
is currently infected with COVID-19. The respondents cite the primary factors that influence
them in accepting the COVID-19 vaccines: effectiveness (89.4%), suggestions from friends or
family (78.3%), and type of vaccines (74.4%). This study provides baseline information on the
knowledge and acceptance of COVID-19 vaccines among the residents of Brgy. Poblacion,
Bayugan City, Agusan del Sur. Hence, effective measures or interventions to promote COVID-
19 vaccination should be directed toward promoting the benefits of vaccination, as well as the
safety and effectiveness of the vaccines.

Keywords: Knowledge, Acceptance, COVID-19, COVID-19 Vaccines, Vaccination

1. INTRODUCTION have been 464,809,377 confirmed cases of

The Coronavirus Disease 2019
(COVID-19) epidemic wreaked havoc on
healthcare systems throughout the world,
posing unprecedented problems. Globally,
as of 7:33 pm CET, 18 March 2022, there
COVID-19, including 6,062,536 deaths,
reported to WHO (WHO, 2022). Within the
Philippines, as of March 20, 2022, there are
already 3.67M confirmed cases and 58,023
deaths (DOH, 2022). Aside from the
healthcare burden, the pandemic has also
resulted in unprecedented social and
economic hardship across the world. Thus,
many countries have adopted several
strategies to manage the spread of the virus,
including social distancing, suspension or
modification of working activities, restricted
movement, and obligatory use of facial
masks (Roma et al., 2020). Although
necessary, these measures have had indirect
negative consequences on national
economies and private health, resulting in an
increase in mental disorders and unhealthy
behaviors (Nicola et al., 2020; Roma et al.,
2020; Mazza et al., 2020; Robinson et al.,
2021). Hence, the event of a vaccine against
the virus is taken into account the simplest
method and a pivotal moment within the
efforts to curb disease spread and start the
resumption of normalcy in the way of life.
In 2020, efforts were made across the globe
to rapidly develop vaccines for COVID19.
Currently, there are 184 candidate vaccines
in preclinical development and 104 in
clinical stages of development (World
Health Organization, 2021). According to
2. METHODOLOGY
2.1 Introduction
This chapter deals with the research
methodology of the study, including the
research design, instrument, procedure and
data analysis.
2.2 Research Design
recent statistics, 18 COVID-19 vaccines
have been authorized and are now in use
across the world. However, despite this
unparalleled scientific discovery, vaccine
hesitancy is seen as an obstacle towards
achieving herd immunity within the battle to
regulate this global pandemic. Vaccine
hesitancy is described as a reluctance or
unwillingness to vaccinate despite the
availability of vaccines. It is one of the ten
most serious contemporary health hazards
(WHO, 2019). Lack of vaccine clinical
studies, vaccine side effects fears, and
allegations of live viruses in vaccinations are
all major roadblocks to the COVID-19
vaccine campaign's success (Elgendy and
Abdelrahim, 2021). This study is conducted
to determine the knowledge and acceptance
of COVID-19 vaccines among the residents
of Brgy. Poblacion, Bayugan City. The
findings from this study will provide data
and vital information to the Bayugan City
LGU to seek out strategies to extend public
understanding and uptake of COVID-19
vaccine
The research design of this study is
descriptive research design, specifically the
quantitative survey method. When utilizing
descriptive research to characterize
features of a population or phenomena being
researched, we are doing descriptive
research. A web- based survey using the
researchers-made questionnaire was
administered to the respondents to determine
their knowledge and acceptance of the
COVID-19 vaccines. The respondents of
this study were the residents of Brgy.
Poblacion, Bayugan City who are 18 years
old and above were chosen randomly, using
convenience non-probability sampling.
2.3 Determination of Sample Size and
Sampling Technique
Based on the CBMS 2018 data of the Office
of the Barangay of Brgy. Poblacion,
Bayugan City, the total population in Brgy.
Poblacion is 19, 825. To reach the research
respondents, convenience sampling and
random sampling methods is used. The
sample size was calculated based on a single
proportion formula, considering a sample
proportion of 50% wherein n = required
sample size (n = Z (α/2) 2 pq/d2) and 95%
CI with 5% margin of error. Therefore, we
2.4 Research Procedure
The web-based survey was conducted on
February 12 and 13, 2022, and was
administered to the respondents using
google forms. The inclusion criteria for
respondent’s eligibility include those more
than 18 years old and residents of Brgy.
Poblacion, Bayugan City only. The google
form access link was shared via online
platforms such as Facebook, emails or other
platforms and this was initiated by the
researchers. The sharing was also facilitated
by the researchers’ family members, friends,
teachers and acquaintances. The researchers
also ensured that privacy and confidentiality
was observed and the data that was gathered
will be used for academic purposes only.
required a sample size of 377 individuals
with ages 18 years old and above as the
study’s target population. However, due to
some reasons such as difficulty in coming
up with this required number of respondents,
we were only able to survey a total of
180 respondents.The formula for calculating
sample size is shown below. The sample
size was also calculated online using this
website:https://www.qualtrics.com/au/experi
encemanagement/research/determine-
sample-size/. The parameters needed for the
calculation was just inputted on the website
in order for the sample size to be calculated.
2.5 Research Instrument
The instrument that was used in this study is
a researchers-made questionnaire which is
encoded in the Google Form. The web-
based questionnaire is developed based on
several studies and related literature which
were conducted in the Philippines and
abroad. The questionnaire is consisting of
four (4) parts: (a) Part I is about determining
the Socio-demographic profiles of the
respondents; (b) Part II 23 is about
determining the knowledge of the
respondents about COVID-19 vaccines; (c)
Part III is about determining the acceptance
of the respondents of the general vaccines
and COVID-19 vaccines; and (d) Part IV is
about determining the factors that influence
the respondents in their acceptance of the member/friend who died due to COVID-19),
COVID-19 vaccine. For the knowledge part, Spearman Correlation analysis was
the respondents were given two (2) options: performed. For these statistical analysis,
Yes, and No. The correct answer for SPSS version 22 was used.
questions 1 to 7 is YES. Meanwhile, the
correct answer for questions 8 to 10 is NO.
One mark was given for any correct answer
and 0 mark for any wrong answer. The
maximum knowledge score was 10, and
those who obtained marks above the median
of the total score (6 and above) will be
categorized as having good knowledge.
Those who obtained 0 – 5 scores will be
categorized as having poor knowledge.

2.6 Data Analysis 3. RESULTS

The researchers gathered the accomplished Table 1

google forms and all data was entered and
analyzed in the Microsoft Excel 2016 Socio-Demographic Profiles of the
spreadsheet. For the socio-demographic Respondents from Brgy. Poblacion,
profiles, the knowledge scores regarding Bayugan City
COVID-19 vaccines, the acceptance of
COVID-19 vaccines and the factors 3.1.1 Socio-demographic Profiles of
influencing the acceptance of COVID-19 Respondents
vaccines, simple descriptive analyses were
computed such as frequencies, percentages,
Profile Frequency Percentage %
mean and standard deviation (SD). To
determine the relationship between the
socio-demographic profiles with COVID-19 Age Group
vaccine knowledge scores and COVID-19
acceptance, chi-square test and Spearman
Correlation Analysis were performed. For 18-19 Years Old 63 35
the nominal profiles (gender, civil status,
presence of chronic diseases, currently
infected with COVID-19, previously 30-39 Years Old 38 21..10

infected with COVID-19 and have a family

member or friend who have been infected
with COVID-19), chi-square test analysis 40-49 Years Old 52 28.90

was performed. For the ordinal profiles (age,

education, monthly income, have a family
50-59 Years Old 18 10

60 Years Old 9 5 Some 4 2.20

and Above Elementary

Sex Elementary 6 3.30

Graduate

Male 90 50
Some High 15 8.30
School

Female 90 50

High School 35 19.40

Graduate or
ALS
Marital Status

Some College or 44 24.40

Single 89 49.40
Vocational

Married 83 46.10
Complete 76 42.20
College or
Higher

Common Law 2 1.10

Relationship
Family Income

Separated 0 0
Poor 2 1.10

(Less than
Widowed/ 3 1.70
₱10,957 per
Widower
month and
below)

Solo Parent 3 1.70

Low Income 48 26.70

(₱10,957 to
Education Attainment ₱21,914 per
month)

No Education 0 0
 (49.40%) respondents, 83 (46.10%)
Lower Middle 65 36.10 respondents are married, 2 (1.10%) are
Income
within the common Law Relationship
(₱21,914 to Status, 3 (1.70%) are widowed and 3
₱41,924)
(1.70%) are separated. In relation with the
Educational Attainment among the
respondents (Table 1, Figure 1D), it
Middle Middle 59 32.80
Income shows that 76 (42.20%) have completed
college or higher, 44 (24.40%) have been to
(₱41,924 to
₱73,367) college or vocational, 35 (19.40%) have
graduated high school or ALS, 15 (8.30%)
have been to high school but has not
Upper Middle 3 1.70 graduated, 6 (3.30%) have graduated
Income
elementary school, 4 (2.20%) have been to
(₱73,367 to elementary but has not graduated. The
₱125,772)
family income of the respondents shows that
65 (36.10%) are within the lower middle
income, 59 (32.80%)are within the middle
Rich 3 1.70
middle income, 48 (26.70%) are within the
(At least low income, 3 (1.70%) are within the upper
219,140 per
month and
middle income, 3 (1.70%) are within the
above) rich category, and 2 (1.10) are within the
poor category (Table 1, Figure 1E).

A total of 180 respondents from Brgy.

Poblacion, Bayugan City, were surveyed in Table 2
this study. The socio-demographic profile of
the respondents is shown in Table 1. Health Profile of the Surveyed Respondents
Majority of the respondents belong to the from Brgy. Poblacion ,Bayugan City
age group 18-29 years old (35 %, Table 1,
Figure 1 A). This is followed by those
belonging to the age group 40-49 years old
Health Profile Percenta
(28.9 %), 30 – 39 years old (21.1 %), 50-59 Frequency ge (%)
years old (10 %) and 60 years old and above
(5 %). In terms of the respondents’ sex Chronic Diseases
(Table 1, Figure 1B), 90 are males (50%)
and 90 are females (50%). The 27 marital Hypertension 2
1.1
status among the respondents (Table 1,
Figure 1C) are mostly single which has 89
 Yes 15 8.3
Hypercholesterole 0 0
mia No 165 91.7

Diabetes Mellitus 0 0
Main source of COVID-19 pandemic information?

World 29 16.1
Chronic Lung 0 0
Health
Diseases
Organizati
on (WHO)

Heart Diseases 0 0

Tv and Radio 167 92.8

Cancer 0 0

Internet and 167 92.8

Chronic Kidney 0 0
Social Media
Diseases

Youtube 57 31.7
None 176 98.3

Tiktok 67 37.2
UTI 1 0.6
Department
Currently Infected with COVID-19? of Health/ 1 0.6
City Health

Yes 1 0.6

Figure 2: Health Profile of the Surveyed Respondents

No 179 99.4 from Brgy. Poblacion, Bayugan City.
(A). Presence of Chronic Diseases; (B) Currently Infected with
Previously infected with COVID-19? COVID-19; (C) Previously
Infected with COVID-19; (D) Have a family member or friend
infected with COVID-19; and
Yes 8 4.4 (E) Lost a family member or friends due to COVID-19.

No 172 95.6

Have a family member or friend infected with COVID-

19?

Yes 34 18.9

No 146 81.1

Figure 3: Main source of information about COVID-19 vaccines

Lost a family member or friends due to COVID-19? used by the respondents.

3.1.3 Respondents’ Knowledge about
COVID-19 Vaccines
The level of knowledge (knowledge scores)
of the respondents about COVID-19
vaccines is shown in Table 3. For the
knowledge part, the respondents were given
two (2) options: Yes, and No. The correct
answer for questions 1 to 7 is YES.
Meanwhile, the correct answer for
questions 8 to 10 is NO. One mark was
given for any correct answer and 0 mark for
any wrong answer. The maximum
knowledge score was 10, and those who
obtained marks above the median of the
total score (6 and above) will be categorized
as having good knowledge. Those who
obtained 0 – 5 scores will be categorized as
having poor knowledge. Table 3 and Figure
4 show that a total of 155 or 86.11% of the
respondents had good knowledge about
COVID-19 vaccines. Meanwhile, about
13.89% or 25 respondents had poor
knowledge about COVID-19.
Table 3
Knowledge scores of respondents
about COVID-19 vaccines (N = 180)
Knowledge Frequency Percentag
level/scores of e (%)
respondents
155 6.11
Good knowledge
(scores 6 and
above)
25 13.89
Poor Knowledge
(scores 0 to 5)
180 100%
Total
Figure 4: Knowledge level of respondents from Brgy. Poblacion,
Bayugan City regarding COVID-19 vaccines.
Table 4 shows the knowledge questions and
scores for each statement. The table also
presents the percentage of the correct and
wrong answers for each statement about
COVID-19 vaccines. The statement
“COVID-19 vaccines will be given via
injection.” had the most percentage of
correct answers (97%). This is followed by
the statement “COVID- 19 vaccine protects
the receiver from getting COVID-19
infection.” wherein 92% of the respondents
got the correct answer. Meanwhile, the
statement with the lowest percentage of
correct answers was “Everyone including
children can receive COVID-19
vaccination” and “COVID-19 vaccine can
also protect us from influenza,” in which
only 13% and 43% of respondents gave the
correct answer.” The summary of the
 answers of the respondents for each knowledge question is shown in Appendix B.

COVID-19 0. 16692 14 8
vaccine 92
protects the (0
receiver from .2
getting 8)
Table 4 COVID-19
infection.*
Knowledge of residents from Brgy.
Poblacion, Bayugan City about COVID- 19
vaccines (N = 180)
COVID-19
vaccination may 0. 12972 51 28
protect other people 71
who do not receive (0
vaccine.* .4
Knowled
5)
geof Mean Correct Wrong
Responde (SD)
nts about
COVID-
19
N % N %
vaccines
Vaccine production 48 52
correct correct involves animal 0. 87 93
study, 3 phases of 49
clinical trials that (0
cover thousands of .5
COVID-19 vaccines 0. 16089 20 11 people and 0)
use inactivated 89 evaluated by the
coronavirus as the (0 authority to ensure
antigen.* .3 the vaccine efficacy
1) and safety.*

COVID-19
vaccines use 0. 15988 21 2
genetic material 88
from coronavirus (0
as the active .3
ingredient.* 2)
COVID-19
vaccines will be 0. 17497 3
given via 96
COVID-19 vaccine 0. 10458 76 42 injection. * (0 6
stimulates our body 58 .2
to produce (0 1)
antibodies, T cells .5
and memory cells to 0) COVID-19
combat COVID-19 vaccines do not 0. 16290 18 10
infection.*
have side 89 of 166 (92%) and the other respondents who
effects. ** (0 said No has the frequency of 14 (8%). For
.3
2) question number 5 (COVID-19 vaccination
may protect other people who do not receive
Everyone
including 0. 28 13 15787 vaccines), the majority of the respondents
children can 23 said Yes with a frequency of 129 (72%) and
receive (0
COVID-19 .4 the other respondents who said No has the
vaccination.** 2) frequency of 51 (28%). For question number
6 (Vaccine production involves animal
COVID-19
study, 3 phases of clinical trials that cover
vaccine can also 0. 77 43 10357
protect us from 44 thousands of people and evaluated by the
influenza/flu. ** (0
authority to ensure the vaccine efficacy and
.5
0) safety), majority of the respondents said Yes
* YES is the correct answer ** NO is the correct with a frequency of 87 (48%) and the other
answer respondents who said No has the frequency
of 93 (52%). For question number 7
Appendix B shows the summary of the (COVID-19 vaccines will be given via
responses for each knowledge question. For injection), the majority of the respondents
question number 1 (COVID-19 vaccines use said Yes with a frequency of 174 (97%) and
inactivated coronavirus as the antigen), the other respondents who said No has the
majority of respondents said Yes with a frequency of 6 (3%). For question number 8
frequency of 160 (89%) and the other (COVID-19 vaccines do not have side
respondents who said No has the frequency effects), the majority of the respondents said
of 20 (11%). For question number 2 No with a frequency of 162 (90%) and the
(COVID-19 vaccines use genetic material other respondents who said Yes had the
from coronavirus as the active ingredient), frequency of 18 (10%). For question number
majority of the respondents said Yes with a 9 (Everyone including children can receive
frequency of 159 (88%) and the other COVID-19 vaccination), the majority of the
respondents who said No has the frequency respondents said Yes with a frequency of
of 21 (12%). For question number 3 157 (87%) and the other respondents who
(COVID-19 vaccine stimulates our body to said No has the frequency of 28 (13%). And
produce antibodies, T cells and memory lastly for question number 10 (COVID- 19
cells to combat COVID-19 infection), vaccine can 33 also protect us from
majority of the respondents said Yes with a influenza/flu), majority of the respondents
frequency of 104 (58%) and the other said Yes with a frequency of 103 (57%) and
respondents who said No has the frequency the other respondents who said No has the
of 76 (42%). For question number 4 frequency of 77 (43%). 4.1.4 Respondent’s
(COVID-19 vaccine protects the receiver Acceptance about COVID-19 Vaccines
from getting COVID-19 infection), majority Table 5 presents the respondents’ expressed
of the respondents said Yes with a frequency acceptance of vaccination, in general, and
COVID-19 vaccination in Particular. Nearly
all surveyed respondents were favorable to (74.4%), and duration of protection (68.3%).
vaccination in general (99.4 %). The The other factors that influence their
majority of the respondents had also been decision are also presented in Table 6 and
vaccinated against influenza (93.3 %) and Figure 5.
COVID-19 vaccines (98.9 %). About 98.9
% of the respondents also declared their Table 5
willingness to be vaccinated against
Respondents’ acceptance of general vaccines
COVID-19. The respondents were also and COVID-19 vaccines
asked if they are willing to receive a
COVID-19 vaccine with an efficacy of 95
%, about 91.9 % of the respondents said Respondents Frequenc Percenta
YES. Meanwhile, when asked if they are Acceptance of y ge (%)
COVID-19
willing to receive a COVID-19 vaccine with vaccines
an efficacy of 70%, about 85.6% of the
respondents said NO. About 91.1% of the 1. Are you
favorable to
respondents are also not willing to receive a vaccination
COVID-10 vaccine with an efficacy of 50%. ?

However, should there be available COVID- Yes 179 99.4

19 vaccine with the desired efficacy, 91.9%
of the respondents would encourage their
No 1 0.6
parents, relatives and friends to get the
vaccines. In terms of general vaccines such
as the flu vaccines, about 88.3% of the 2. Are you
vaccinated
respondents already received the seasonal against
flu shot in the last 12 months, and about influenza
(flu)?
95.6% of the respondents are planning to
receive a seasonal flu vaccine in the next Yes 168 93.3

year. Table 6 presents the factors that

influence the acceptance of the respondents No 12 6.7
of the COVID-19 vaccines. According to
99.4% of the respondents, the government 3. Are you
should provide free COVID-19 vaccines to vaccinated
against
the high risk groups. When they were asked COVID-
what are the factors influencing their 19?

acceptance of the COVID-19 vaccines Yes 178 98.9

(Table 6, Figure 5), the effectiveness of the
vaccines ranked first (89.4%) thus it greatly
No 2 1.1
influences their acceptance of the COVID-
19 vaccines. This is followed by these
influencing factors: Suggestion from friends
or family members (78.3%), type of vaccine
 receiving
4. If NO, are you the
willing to be
vaccinated against vaccine?
COVID-19?

Yes 16 8.9

No 164 91.1
Yes 178 98.8

No 1.2 8. If a COVID-
2
19 vaccine was
available with
the desired
5. If a COVID-19
efficacy, would
vaccine is
you encourage
available with an
your parents/
efficacy of 95%,
relatives/
would you be a
friends to get
candidate for
the vaccine?
receiving all
shots?
Yes 164 91.1

Yes 164 91.1

No 16 8.9
No 16 8.9

6. If a COVID-19
vaccine is
available with an
efficacy of 70%,
9. Did you receive
would you be a
the seasonal flu
candidate for
shot in the last 12
receiving the
months?
vaccine?

Yes 26 14.4
Yes 159 88.3

No 154 85.6

No 21 11.7
7. If a
COVID-19
vaccine is
available 10. Are you
with an planning to receive
efficacy of a seasonal flu
50%, would vaccine in the next
you be a year?
candidate
for
 Number of deaths due to 37 25
Yes 172 95.6 COVID-19

Health status 89 49.4

No 8 4.4 Cost 103 57.2

Duration of protection 123 68.3

Table 6 134 74.4

Type of vaccine
Factors influencing acceptance for
COVID-19 vaccine
39 21.7
Number of vaccine doses

Fact Frequenc Percent Country that produces the 50 27.8

ors y age vaccine
(%)
Suggestion from friends or 141 78.3
family members
1. In your opinion, should
the government provide
free COVID-19 vaccines to
the high-risk groups?

Yes 179 99.4

No 1 0.6

2. What are the factors

that influence your
decision to take the
COVID-19 vaccine?
(Check all that
applies; This question
allows multiple Figure 5. Factors that influence the
responses.) acceptance of COVID-19 Vaccines among the
respondents from Brgy. Poblacion, Bayugan City
Effectiveness 161 89.4
3.1.3 Relationship of
Suggestions from 103 6.7 Profiles with Knowledge and
doctors or Department
of Health (DOH) Acceptance of COVID-19
Vaccines
Number of positive 45 25
COVID-19 cases
To determine the relationship
between the sociodemographic
profiles with COVID- 19 vaccine
Adverse effects 43 23.9
knowledge scores and COVID-19
acceptance, chi-square test and
Spearman Correlation Analysis
were performed. For the nominal Profiles Conclusio
Knowledge
profiles (gender, civil status, About COVID-19
n

presence of chronic diseases, Vaccines

currently infected with COVID-

19, previously infected with
COVID-19 and have a family
member or friend who have been
𝞆2-test
infected with COVID-19), chi- p-
square test analysis was value

performed. For the ordinal profiles

(age, education, monthly income, Gender 0.588 0.443 Not
have a family member/friend who Sign
ifica
died due to COVID-19), Spearman nt
Correlation analysis was
performed. For these statistical Civil Status 14.929 0.005* Sign
analyses, SPSS version 22 was ifica
nt
used.

Table 7 presents the relationship

Chronic Disease 0.964 0.326 Not
between the respondent’s profile Sign
and their knowledge about ifica
nt
COVID-19 vaccines. Among the
profiles, the following have
Currently
significant relationship (p < 0.05) Infected
0.964 0.326 Not
Sign
with the knowledge about with
ifica
COVID-
COVID-19 vaccines: age, civil 19
nt

status, monthly income and have a

Previously
family member or friend who have Infected
2.995 0.084 Not
Sign
COVID-19. This means that these with
ifica
COVID-19
profiles may have influenced their nt

knowledge about COVID-19

vaccines. Have a
family 7.832 0.005* Significan
member/frie t
nd been
Table 7 infected with
COVID-19

Relationship between Socio-

demographic Profiles and Knowledge of the
respondents about Covid-19 vaccines
 acceptance (Table 8). These
Knowledge are the monthly income and if
Profiles About Covid-19 Conclusio
Vaccines n the respondent is currently
infected with COVID-19.

Table 8

Relationship between Socio-demographic

P-value Profiles and Acceptance of COVID-19
vaccines
Spearman’s
Correlation
coefficient

Profiles Conclus
Age -0.199 0.007* Sign Acceptance of
ion
ifica COVID-19
nt Vaccines

𝞆2-
test P-
Education -0.121 0.106 Not
Sign value
ifica
nt

Gender 2.918 0.08 N

8 ot
Monthly 0.164 0.028* Sign Si
Income ifica gn
nt ifi
ca
nt

Have family
members or 0071 0.790 Not
friends died Significan Civil Status 0.405 0.98 N
due to t 2 ot
COVID-19 Si
gn
ifi
ca
nt
*Correlation is significant if P-value < 0.05 level of
significance

In terms of acceptance Chronic Disease 0.052 0.82 N

0 ot
of the COVID-19 vaccines, Si
only two profiles have gn
ifi
significant relationship (p < ca
0.05) with COVID-19 vaccines
 nt nt

Currently
5.156 0.02 Si
Infected With Monthly Income 0.166 0.02 Si
0* gn
COVID-19 6* gn
ifi
ifi
ca
ca
nt
nt
Previously
0.376 0.54 N
Infected with
0 ot Have family 0.052 0.820 Not
COVID-19
Si members or Signific
gn friends died ant
ifi due to
ca COVID- 19
nt

Not *Correlation is significant if P-value < 0.05 level of significance

Have a family Signific
member/friend 2.036 0.154 ant
been infected 4. Conclusions
with COVID-
19 This study provides baseline information on
the knowledge and acceptance of COVID-
19 vaccines among the residents of Brgy.
Profiles Acceptance of COVID-19
Vaccines Conclus
Poblacion, Bayugan City, Agusan del Sur.
ion The residents have good knowledge and the
knowledge score was relatively high. The
knowledge is significantly associated with
Spearman age, civil status, monthly income, and
’s P-value having a family member or friend who has
Correlatio
n COVID-19. There is also a high acceptance
coefficient
rate among the respondents, and their
acceptance is significantly associated with
monthly income and if the respondent is
Age -0.064 0.395 N
ot
currently infected with COVID-19. In order
Si to promote knowledge and acceptance of
gn
ifi
COVID-19 vaccines, effective measures or
ca interventions to promote COVID-19
nt
vaccination should be directed towards
promoting the benefits of vaccination, as
well as the safety and effectiveness of the
Education 0.022 0.767 N
ot vaccines.
Si
gn
ifi
ca
5. References
Abdullah AC, MZ NA, Rosliza AM.
Predictors for inadequate knowledge and
negative
attitude towards childhood immunization
among parents in Hulu Langat,
Selangor, Malaysia. Malaysian J Public
Health Med. 2018; 18(1):102–12.
Anderson, R. M.; Vegvari, C.; Truscott, J.;
Collyer, B. S. Challenges in creating herd
immunity to SARS-CoV-2 infection by
mass vaccination. The Lancet 2020,
396(10263), 1614-1616.
https://doi.org/10.1016/s0140-
6736(20)32318-7
Bautista Jr, A. P., Bleza, D. G., Balibrea, D.
M., & Equiza, C. (2021). Acceptability of
Vaccination Against COVID-19 Among
Selected Residents of the Cities of
Caloocan, Malabon, and Navotas,
Philippines.
Bhatraju PK, Ghassemieh BJ, Nichols M,
Kim R, Jerome KR, Nalla AK, et al. Covid-
19
in critically ill patients in the Seattle region -
case series. N Engl J Med.
2020;382(21):2012–22.
https://doi.org/10.1056/NEJMoa2004500.
Chan AKM, Nickson CP, Rudolph JW, Lee
A, Joynt GM. Social media for rapid
knowledge dissemination: early experience
from the COVID-19 pandemic.
Anaesthesia. 2020; 75(12):1579–82.
https://doi.org/10.1111/anae.15057 PMID:
32227594
Dong E, Du H, Gardner L. An interactive
web-based dashboard to track COVID-19 in
real time. Lancet Infect Dis.
2020;20(5):533–4.
https://doi.org/10.1016/S1473-
3099(20)30120-1.
Doshi P. Will covid-19 vaccines save lives?
Current trials aren’t designed to tell us.
BMJ.
2020;371. pmid:33087398
Dror AA, Eisenbach N, Taiber S, Morozov
NG, Mizrachi M, Zigron A, et al. Vaccine
hesitancy: the next challenge in the fight
against COVID-19. Eur J Epidemiol.
2020;35(8):775–9. pmid:32785815
Elgendy, M. O., & Abdelrahim, M. E.
(2021). Public awareness about coronavirus
vaccine, vaccine acceptance, and hesitancy.
Journal of Medical Virology.
Elharake, J. A., Galal, B., Alqahtani, S. A.,
Kattan, R. F., Barry, M. A., Temsah, M. H.,
&
Memish, Z. A. (2021). COVID-19 vaccine
acceptance among health care
workers in the Kingdom of Saudi Arabia.
International Journal of Infectious
Diseases, 109, 286-293.
García LY, Cerda AA. Acceptance of a
COVID-19 vaccine: a multifactorial
consideration.
Vaccine. 2020;38(48):7587.
https://doi.org/10.1016/j.vaccine.2020.10.02
6.
Grasselli G, Zangrillo A, Zanella A,
Antonelli M, Cabrini L, Castelli A, et al.
Baseline
characteristics and outcomes of 1591
patients infected with SARS-CoV-2
admitted to ICUs of the Lombardy region,
Italy. JAMA.
2020;323(16):1574– 81.
https://doi.org/10.1001/jama.2020.5394.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ,
He JX, et al. Clinical characteristics of
coronavirus disease 2019 in China. N Engl J
Med.
2020;382(18):1708– 20.
https://doi.org/10.1056/NEJMoa2002032.
Harrison EA, Wu JW. Vaccine confidence
in the time of COVID-19. Eur J Epidemiol.
2020;35(4):325–30.
https://doi.org/10.1007/s10654-020-00634-
3.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, et al. Clinical features of patients infected
with 2019 Novel coronavirus in Wuhan,
China. Lancet.
2020;395(10223):497–506. Kaur SP, Gupta
V. COVID-19 Vaccine: A
comprehensive status report. Virus Res.
2020;198114. pmid:32800805
Li X, Liu Q. Social media use, eHealth
literacy, disease knowledge, and preventive
behaviors in the COVID-19 pandemic:
cross-sectional study on Chinese
58
netizens. J Med Internet Res. 2020;
22(10):e19684.
https://doi.org/10.2196/19684 PMID:
33006940
Mathieu E, Ritchie H, Ortiz-Ospina E, Roser
M, Hasell J, Appel C, et al. A global
database of COVID-19 vaccinations. Nat
Hum Behav. 2021;1–7. pmid:33473201
Mazza, C.; Ricci, E.; Marchetti, D.;
Fontanesi, L.; Di Giandomenico, S.;
Verrocchio,
M.C.; Roma, P. How Personality Relates to
Distress in Parents during the
Covid-19 Lockdown: The Mediating Role of
Child’s Emotional and Behavioral
Difficulties and the Moderating Effect of
Living with Other People. Int. J. Environ.
Res. Public Health 2020, 17, 6236.
Meo SA, Bukhari IA, Akram J, Meo AS,
Klonoff DC. COVID-19 vaccines:
Comparison
of biological, pharmacological
characteristics and adverse effects of
Pfizer/BioNTech and Moderna Vaccines.
Eur Rev Med Pharmacol Sci.
2021;25(3):1663–9. pmid:33629336 Nagy
A, Alhatlani B: An overview of current
COVID-19 vaccine platforms. Comput
Struct Biotechnol J 2021, 19:2508-2517
Mirowsky J, Ross CE. Education, personal
control, lifestyle and health: A human
capital hypothesis. Res Aging. 1998;20:
415–449.
doi:10.1177/0164027598204003
Nicola, M.; Alsafi, Z.; Sohrabi, C.; Kerwan,
A.; Al-Jabir, A.; Iosifidis, C.; Agha, M.;
Agha,
R. The socio-economic implications of the
coronavirus pandemic (COVID-19): A
review. Int. J. Surgery 2020, 78, 185–193.
Ooi PL, Heng ZY, Boon KY. Factors
Influencing Parents’awareness Regarding
Childhood Immunization: Findings
Cross-Sectional Study In Northeast
Penang Island District, Malaysia. Int J
Public Heal Clin Sci. 2019; 6(3):130–42.
Paterson P, Meurice F, Stanberry LR,
Glismann S, Rosenthal SL, Larson HJ.
Vaccine
hesitancy and healthcare providers. Vaccine.
2016;34(52):6700–
6.
https://doi.org/10.1016/j.vaccine.2016.10.04
2.
59
Pfizer Inc. Pfizer and Biontech Conclude
Phase 3 Study Of Covid-19 Vaccine
Candidate, Meeting All Primary Efficacy
Endpoints. 2020. [cited 2020 Dec
12] Available from
https://www.pfizer.com/news/press-
release/press-releasedetail/
pfizer-and-biontech- conclude-phase-3-
study-covid-19-vaccine
Puri N, Coomes EA, Haghbayan H,
Gunaratne K. Social media and vaccine
hesitancy:
new updates for the era of COVID-19 and
globalized infectious diseases. Hum
Vaccin Immunother. 2020;1–8.
pmid:32693678.
Of Reuters. False claim: A COVID-19 vaccine
will genetically modify humans [Internet].
2020. [cited 2021 Sept 15]. Available from:
https://www.reuters.com/article/ukfactcheck
-
covid- 19-vaccine-modify-
idUSKBN22U2BZ
Robinson, E.; Boyland, E.; Chisholm, A.;
Harrold, J.; Maloney, N.G.; Marty, L.;
Mead,
B.R.; Noonan, R.; Hardman, C.A. Obesity,
eating behavior and physical activity
during the COVID-19 lockdown: A study of
UK adults. Appetite 2021, 156,
104853.
Roma, P.; Monaro, M.; Muzi, L.; Colasanti,
M.; Ricci, E.; Biondi, S.; Napoli, C.;
Ferracuti, S.; Mazza, C. How to improve
compliance with protective health
measures during the COVID-19 outbreak:
Testing a moderated mediation model
and machine learning algorithms. Int. J.
Environ. Res. Public Health 2020, 17,
7252.
Roma, P.; Monaro, M.; Colasanti, M.; Ricci,
E.; Biondi, S.; Di Domenico, A.;
Verrocchio, M.C.; Napoli, C.; Ferracuti, S.;
Mazza, C. A 2-month follow-up study
of psychological distress among Italian
people during the COVID-19 lockdown.
Int. J. Environ. Res. Public Health 2020, 17,
8180.
Shekhar R, Sheikh AB, Upadhyay S, Singh
M, Kottewar S, Mir H, et al. COVID-19
vaccine acceptance among health care
workers in the United States. Vaccines.
2021;9(2):119. pmid:33546165
60
Tasnim S, Hossain MM, Mazumder H.
Impact of Rumors and Misinformation on
COVID- 19 in Social Media. J Prev Med
Public Health [Internet]. 2020/04/02.
2020 May; 53(3):171–4. Available from:
https://pubmed.ncbi.nlm.nih.gov/32498140
https://doi.org/10.3961/jpmph.20.094
PMID: 32498140
Wagner, A. L.; Huang, Z.; Ren, J.; Laffoon,
M.; Ji, M.; Pinckney, L. C.; … Zikmund-
Fisher, B. J. Vaccine Hesitancy and
Concerns About Vaccine Safety and
Effectiveness in Shanghai, China. American
Journal of Preventive Medicine
2021, 60(1).
https://doi.org/10.1016/j.amepre.2020.09.00
3
Wakefield MA, Loken B, Hornik RC. Use
of mass media campaigns to change health
behaviour. Lancet. 2010; 376(9748):1261–
71. https://doi.org/10.1016/S0140-
6736(10)60809-4 PMID: 20933263